Like Countable?

Install the App
TRY NOW

senate Bill S. 1348

Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017

bill Progress


  • Not enacted
    The President has not signed this bill
  • The house has not voted
  • The senate has not voted
      senate Committees
      Committee on Finance
    IntroducedJune 13th, 2017

Bill Details

Official information provided by the Congressional Research Service. Learn more or make a suggestion.
The Congressional Research Service writes summaries for most legislation. These summaries are listed here. Countable will update some legislation with a revised summary, title or other key elements.

Suggest an update to this bill using our form.

Title

Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017

Official Title

A bill to amend title XI of the Social Security Act to require drug manufacturers to publicly justify unnecessary price increases.

Summary

Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 This bill amends title XI (General Provisions) of the Social Security Act to require manufacturers of  drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare & Medicaid Services (CMS) written justification for certain increases in drug prices. The CMS shall publish each submission, together with an easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill. A manufacturer that does not comply with the bill's requirements shall be subject to civil monetary penalties.

    There are currently no opinions on this bill, be the first to add one!